Effect Of 1% Alendronate Gel as a Local Host Modulating Agent on IL-6 Levels in GCF in Non-Surgical Management of Chronic Periodontitis - A Clinical Trial & An Immunological Analysis
Phase 2
- Conditions
- Generalized Chronic Periodontitis
- Registration Number
- JPRN-UMIN000032428
- Lead Sponsor
- ITS Dental College, Hospital and Research Centre, 47, Knowledge Park III, I.T.S. Dental College, Hospital and research Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Allergy to ALN/Bisphosphonate group of drugs. Systemic ALN/Bisphosphonate group of drugs therapy. Patients suffering from Aggressive Periodontitis. Smokers and tobacco chewers. Alcoholics. Immunocompromised patients. Pregnant or lactating females. Radiographic evidence of vertical bone loss. Patient suffering from any inflammatory bone disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method